← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2007Last known activity
Nov 8, 2017
Timeline
1950s
- Jun 1, 1951
Kuhnil Pharmaceutical Co., Ltd.— Founded
Drugs by trial phase (10 distinct, 13 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Dyslipidemias
- Dyssomnias
- Fatty Liver
- Glomerulonephritis, IGA
- Hypercholesterolemia
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertriglyceridemia
- Kidney Diseases
- Liver Diseases
- Mental Disorders
- Non-alcoholic Fatty Liver Disease
- Osteoarthritis
- Parasomnias
- Parkinson Disease
- REM Sleep Behavior Disorder
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Stomach Neoplasms
Recent trials (13)
- NCT03222206CollaboratorPhase 4Nov 8, 2017
- NCT02789592CollaboratorPhase 2Jul 1, 2016
- NCT03482180Lead sponsorPhase 3Jun 3, 2016
- NCT03258294CollaboratorPhase 4Jan 13, 2016
- NCT02768077Lead sponsorPhase 4Jan 1, 2016
- NCT03026933Lead sponsorPhase 3May 1, 2014
- NCT02035215Lead sponsorPhase 3Jan 1, 2014
- NCT02087722Lead sponsorPhase 3Aug 1, 2013
- NCT01813253Lead sponsorPhase 3Mar 1, 2013
- NCT01450228Lead sponsorPhase 3Mar 1, 2011
- NCT00758927CollaboratorPhase 4Jul 1, 2009
- NCT02305355Lead sponsorPhase 4Feb 1, 2009
- NCT00549692Lead sponsorPhase 3Nov 1, 2007
Details
- Founded
- Seoul, KR Jun 1, 1951
- Last known activity
- Nov 8, 2017